Joachim Bischof
5PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 10, 2022
CK1 Is a Druggable Regulator of Microtubule Dynamics and Microtubule-Associated Processes.Aileen Roth, Adrian Gihring, Joachim Bischof
|Aug 27, 2021
Assessing the Inhibitory Potential of Kinase Inhibitors In Vitro: Major Pitfalls and Suggestions for Improving Comparability of Data Using CK1 Inhibitors as an Example.Aileen Roth, Adrian Gihring, Florian Göser
|Jul 02, 2021
CK1δ-Derived Peptides as Novel Tools Inhibiting the Interactions between CK1δ and APP695 to Modulate the Pathogenic Metabolism of APP.Aileen Roth, Fabian Gärtner, Katja Mayer
|Dec 11, 2019
Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.Congxing Liu, Lydia Witt, Chiara Ianes
|May 17, 2019
The kinase domain of CK1δ can be phosphorylated by Chk1.Thomas Böhm, Zhigang Meng, Philipp Haas
Pageof 1
